Antibody to varicella-zoster virus immediate-early protein 62 augments allodynia in zoster via brain-derived neurotrophic factor

Journal of Virology

Volumn 84, Issue 3, 2010, Pages 1616-1624

  Hama, Yuka ^a   Shiraki, Kimiyasu ^a   Yoshida, Yoshihiro ^a   Maruyama, Atsushi ^b   Yasuda, Makoto ^a   Tsuda, Masaaki ^a   Honda, Mariko ^c   Takahashi, Michiaki ^d   Higuchi, Hiroshi ^e   Takasaki, Ichiro ^a   Daikoku, Tohru ^a   Tsumoto, Tadaharu ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Osaka University   (Japan)

^e NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 62; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IMMEDIATE EARLY PROTEIN 62; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFECT; EMBRYO; HERPES ZOSTER; HUMAN; HUMAN CELL; MALE; MOUSE; NERVE INJURY; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN DEFECT; SPINAL CORD DORSAL HORN; VARICELLA ZOSTER VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; CROSS REACTIONS; DNA PRIMERS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 3; MUS;

EID: 73949091596     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02061-09     Document Type: Article

References (38)

1. Aid, T., A. Kazantseva, M. Piirsoo, K. Palm, and T. Timmusk. 2007. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85:525-535.
2. Alder, J., S. Thakker-Varia, D. A. Bangasser, M. Kuroiwa, M. R. Plummer, T. J. Shors, and I. B. Black. 2003. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 23:10800-10808.
3. Bibel, M., and Y. A. Barde. 2000. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14:2919-2937.
4. Bramham, C. R., and E. Messaoudi. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76:99-125.
5. Burgoon, C. F., Jr., J. S. Burgoon, and G. D. Baldridge. 1957. The natural history of herpes zoster. JAMA 164:265-269.
6. Cohrs, R. J., M. Barbour, and D. H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 70:2789-2796.
7. Coull, J. A., S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C. Gravel, M. W. Salter, and Y. De Koninck. 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-1021.
8. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
9. Devine, L., M. E. Hodsdon, M. A. Daniels, S. C. Jameson, and P. B. Kavathas. 2004. Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation. Immunol. Lett. 93:123-130.
10. Dworkin, R. H., and R. K. Portenoy. 1996. Pain and its persistence in herpes zoster. Pain 67:241-251.
11. Echevarría, J. M., I. Casas, and P. Martinez-Martin. 1997. Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology 40:72-84.
12. Garry, E. M., A. Delaney, H. A. Anderson, E. C. Sirinathsinghji, R. H. Clapp, W. J. Martin, P. R. Kinchington, D. L. Krah, C. Abbadie, and S. M. Fleetwood-Walker. 2005. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118:97-111.
13. Gilden, D. H., R. J. Cohrs, A. R. Hayward, M. Wellish, and R. Mahalingam. 2003. Chronic varicella-zoster virus ganglionitis-a possible cause of postherpetic neuralgia. J. Neurovirol. 9:404-407.
14. Gilden, D. H., R. J. Cohrs, and R. Mahalingam. 2005. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology 64:21-25.
15. Imamura, L., M. Yasuda, K. Kuramitsu, D. Hara, A. Tabuchi, and M. Tsuda. 2006. Deltamethrin, a pyrethroid insecticide, is a potent inducer for the activity-dependent gene expression of brain-derived neurotrophic factor in neurons. J. Pharmacol. Exp. Ther. 316:136-143.
16. Johnson, R. W., and R. H. Dworkin. 2003. Treatment of herpes zoster and postherpetic neuralgia. BMJ 326:748-750.
17. Jung, B. F., R. W. Johnson, D. R. Griffin, and R. H. Dworkin. 2004. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62:1545-1551.
18. Kohara, K., A. Kitamura, M. Morishima, and T. Tsumoto. 2001. Activitydependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291:2419-2423.
19. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA 95:7080-7085.
20. Mahalingam, R., M. Wellish, R. Cohrs, S. Debrus, J. Piette, B. Rentier, and D. H. Gilden. 1996. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. USA 93:2122-2124.
21. Malcangio, M., and V. Lessmann. 2003. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol. Sci. 24:116-121.
22. Mannion, R. J., M. Costigan, I. Decosterd, F. Amaya, Q. P. Ma, J. C. Holstege, R. R. Ji, A. Acheson, R. M. Lindsay, G. A. Wilkinson, and C. J. Woolf. 1999. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc. Natl. Acad. Sci. USA 96:9385-9390.
23. Matayoshi, S., N. Jiang, T. Katafuchi, K. Koga, H. Furue, T. Yasaka, T. Nakatsuka, X. F. Zhou, Y. Kawasaki, N. Tanaka, and M. Yoshimura. 2005. Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat. J. Physiol. 569:685-695.
24. Murase, K., and M. Randic. 1983. Electrophysiological properties of rat spinal dorsal horn neurones in vitro: calcium-dependent action potentials. J. Physiol. 334:141-153.
25. Nagappan, G., and B. Lu. 2005. Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci. 28:464-471.
26. Nakajima, K., Y. Tohyama, S. Kohsaka, and T. Kurihara. 2002. Ceramide activates microglia to enhance the production/secretion of brain-derived neurotrophic factor (BDNF) without induction of deleterious factors in vitro. J. Neurochem. 80:697-705.
27. Obata, K., and K. Noguchi. 2006. BDNF in sensory neurons and chronic pain. Neurosci. Res. 55:1-10.
28. Obata, K., H. Yamanaka, T. Fukuoka, D. Yi, A. Tokunaga, N. Hashimoto, H. Yoshikawa, and K. Noguchi. 2003. Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain 101:65-77.
29. Reichelt, M., L. Zerboni, and A. M. Arvin. 2008. Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J. Virol. 82:3971-3983.
30. Shiraki, K., and R. W. Hyman. 1987. The immediate early proteins of varicella-zoster virus. Virology 156:423-426.
31. Shiraki, K., T. Okuno, K. Yamanishi, and M. Takahashi. 1982. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). J. Gen. Virol. 61:255-269.
32. Shiraki, K., Y. Yoshida, Y. Asano, K. Yamanishi, and M. Takahashi. 2003. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J. Infect. Dis. 188:1875-1877.
33. Strangfeld, A., J. Listing, P. Herzer, A. Liebhaber, K. Rockwitz, C. Richter, and A. Zink. 2009. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301:737-744.
34. Tabuchi, A., H. Sakaya, T. Kisukeda, H. Fushiki, and M. Tsuda. 2002. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J. Biol. Chem. 277:35920-35931.
35. Takasaki, I., T. Kurihara, H. Saegusa, S. Zong, and T. Tanabe. 2005. Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. Eur. J. Pharmacol. 524:80-83.
36. Tamamaki, N., Y. Yanagawa, R. Tomioka, J. Miyazaki, K. Obata, and T. Kaneko. 2003. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 467:60-79.
37. Thoenen, H., and M. Sendtner. 2002. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5(Suppl.):1046-1050.
38. Thompson, S. W., D. L. Bennett, B. J. Kerr, E. J. Bradbury, and S. B. McMahon. 1999. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc. Natl. Acad. Sci. USA 96:7714-7718.